MedTrace Logo

Executive Functioning in TBI From Rehabilitation to Social Reintegration: COMPASS

NCT01816061 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 91

Last updated 2019-09-25

Study results available
· View outcomes & findings →

Summary

Interventional, controlled clinical trial with two arms, 110 Veterans with TBI and PTSD

Conditions

Interventions

BEHAVIORAL

Experimental - COMPASS

Controlled randomized clinical trial. Fifty-five participants in the intervention group will receive eight goal self-management sessions over a period of approximately ten weeks.

BEHAVIORAL

Control - COMPASS

Increased hours of patient-provider interactions Group.

Sponsors & Collaborators

  • VA Office of Research and Development

    lead FED

Principal Investigators

  • Joel Scholten, MD · DCVAMC

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
21 Years
Max Age
55 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2014-03-12
Primary Completion
2017-03-06
Completion
2018-03-31

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01816061 on ClinicalTrials.gov